These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 30102990)

  • 1. Using bioreactors to study the effects of drugs on the human microbiota.
    Guzman-Rodriguez M; McDonald JAK; Hyde R; Allen-Vercoe E; Claud EC; Sheth PM; Petrof EO
    Methods; 2018 Oct; 149():31-41. PubMed ID: 30102990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gut Microbiota-Mediated Drug-Antibiotic Interactions.
    Kim DH
    Drug Metab Dispos; 2015 Oct; 43(10):1581-9. PubMed ID: 25926432
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
    Swanson HI
    Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimization of metabolomics of defined in vitro gut microbial ecosystems.
    Wissenbach DK; Oliphant K; Rolle-Kampczyk U; Yen S; Höke H; Baumann S; Haange SB; Verdu EF; Allen-Vercoe E; von Bergen M
    Int J Med Microbiol; 2016 Aug; 306(5):280-289. PubMed ID: 27020116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review of metabolic potential of human gut microbiome in human nutrition.
    Yadav M; Verma MK; Chauhan NS
    Arch Microbiol; 2018 Mar; 200(2):203-217. PubMed ID: 29188341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut Microbial Changes, Interactions, and Their Implications on Human Lifecycle: An Ageing Perspective.
    Vemuri R; Gundamaraju R; Shastri MD; Shukla SD; Kalpurath K; Ball M; Tristram S; Shankar EM; Ahuja K; Eri R
    Biomed Res Int; 2018; 2018():4178607. PubMed ID: 29682542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of gut microbiota in association between GLP-1/GLP-1 receptor expression and gastrointestinal motility.
    Yang M; Fukui H; Eda H; Xu X; Kitayama Y; Hara K; Kodani M; Tomita T; Oshima T; Watari J; Miwa H
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G367-G373. PubMed ID: 28154011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deciphering the Chemical Lexicon of Host-Gut Microbiota Interactions.
    Nicolas GR; Chang PV
    Trends Pharmacol Sci; 2019 Jun; 40(6):430-445. PubMed ID: 31079848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacteriophage-Mediated Perturbation of Defined Bacterial Communities in an
    Attai H; Wilde J; Liu R; Chopyk J; Garcia AG; Allen-Vercoe E; Pride D
    Microbiol Spectr; 2022 Jun; 10(3):e0113522. PubMed ID: 35638779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gut microbial metabolism and colon cancer: can manipulations of the microbiota be useful in the management of gastrointestinal health?
    Belcheva A; Irrazabal T; Martin A
    Bioessays; 2015 Apr; 37(4):403-12. PubMed ID: 25601287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gut microbiota: what is its place in pharmacology?
    Tarasiuk A; Fichna J
    Expert Rev Clin Pharmacol; 2019 Oct; 12(10):921-930. PubMed ID: 31544557
    [No Abstract]   [Full Text] [Related]  

  • 12. Antibiotics and the developing infant gut microbiota and resistome.
    Gibson MK; Crofts TS; Dantas G
    Curr Opin Microbiol; 2015 Oct; 27():51-6. PubMed ID: 26241507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Use of Defined Microbial Communities To Model Host-Microbe Interactions in the Human Gut.
    Elzinga J; van der Oost J; de Vos WM; Smidt H
    Microbiol Mol Biol Rev; 2019 May; 83(2):. PubMed ID: 30867232
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocannabinoids--at the crossroads between the gut microbiota and host metabolism.
    Cani PD; Plovier H; Van Hul M; Geurts L; Delzenne NM; Druart C; Everard A
    Nat Rev Endocrinol; 2016 Mar; 12(3):133-43. PubMed ID: 26678807
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The complex interplay of diet, xenobiotics, and microbial metabolism in the gut: Implications for clinical outcomes.
    Taguer M; Maurice CF
    Clin Pharmacol Ther; 2016 Jun; 99(6):588-99. PubMed ID: 26950037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The gut mycobiota: insights into analysis, environmental interactions and role in gastrointestinal diseases.
    Richard ML; Sokol H
    Nat Rev Gastroenterol Hepatol; 2019 Jun; 16(6):331-345. PubMed ID: 30824884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Our gut microbiota: a long walk to homeostasis.
    Dicks LMT; Geldenhuys J; Mikkelsen LS; Brandsborg E; Marcotte H
    Benef Microbes; 2018 Jan; 9(1):3-20. PubMed ID: 29022388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis of the Microbial Diversity Cultured in Bioreactors Simulating the Gut Microbiome.
    Garcia Mendez DF; Egan S; Wist J; Holmes E; Sanabria J
    Microb Ecol; 2024 Apr; 87(1):57. PubMed ID: 38587527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alzheimer's disease and gut microbiota.
    Hu X; Wang T; Jin F
    Sci China Life Sci; 2016 Oct; 59(10):1006-1023. PubMed ID: 27566465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gut metabolome meets microbiome: A methodological perspective to understand the relationship between host and microbe.
    Lamichhane S; Sen P; Dickens AM; Orešič M; Bertram HC
    Methods; 2018 Oct; 149():3-12. PubMed ID: 29715508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.